17,000 Jobs Gone: How HHS Workforce Cuts Are Reshaping Healthcare Careers in 2026

One year ago, the Department of Health and Human Services began the largest workforce reduction in its history. Today, the fallout is impossible to ignore. From delayed drug approvals at the Food and Drug Administration to a hobbled disease response at the Centers for Disease Control and Prevention, the ripple effects of cutting more than 17,000 federal health workers are reaching every corner of the American healthcare system. For the thousands of professionals who lost their jobs and the millions who depend on these agencies, the consequences are deeply personal. Metaintro breaks down what happened, what it means for the healthcare job market, and where opportunities still exist.

How Did the HHS Layoffs Unfold?

The restructuring began in March 2025, when HHS Secretary Robert F. Kennedy Jr. announced plans to eliminate roughly 20,000 positions, cutting the department from 82,000 full-time employees to approximately 62,000. The reductions came in multiple waves. First, around 10,000 workers accepted voluntary separation incentives and early retirement packages. Then, on April 1, 2025, formal reduction-in-force (RIF) notices went out to another 10,000 employees across nearly every HHS division.

The rollout was chaotic. According to reporting by NPR, employees at the CDC, FDA, and National Institutes of Health described being turned away after showing up to work, with no clear communication about who was being let go or why. An estimated 20 percent of the cuts were later acknowledged as errors by Kennedy himself, and hundreds of laid-off staff were eventually reinstated, according to BioPharma Dive.

Legal challenges followed. Courts temporarily blocked some terminations, but after a Supreme Court ruling in July 2025, HHS was permitted to finalize a portion of the layoffs, with official separations taking effect on July 14, 2025.

By early 2026, the damage was clear. The HHS workforce had fallen from 92,000 to just under 75,000, a net loss of more than 17,000 employees, with an additional 3,000 departing between fall 2025 and January 2026 through attrition alone.

Which Agencies Were Hit the Hardest?

The cuts reached virtually every agency under the HHS umbrella, but some were hit far harder than others.

The Food and Drug Administration lost approximately 2,519 employees in the April RIF wave, with total planned reductions of around 3,500, representing roughly 20 percent of its workforce. The Centers for Disease Control and Prevention shed 2,473 employees in the same wave, also losing close to one-fifth of its staff. The National Institutes of Health saw 1,312 employees laid off, disrupting ongoing biomedical research and clinical trials.

Smaller agencies were devastated even more severely. The Agency for Healthcare Research and Quality (AHRQ), which conducts critical health quality and safety research, lost more than 50 percent of its staff. The Administration for Community Living, which supports older adults and people with disabilities, faced similarly steep cuts exceeding 50 percent. The National Institute for Occupational Safety and Health (NIOSH) expected to lose roughly 873 staff members, about two-thirds of its entire workforce.

Communications, policy, IT, and human resources divisions across multiple agencies were gutted or shuttered entirely. Offices focused on health equity and minority health were closed as part of what HHS described as a broader reorganization effort.

What Has the Impact Been on Healthcare Services?

One year into the restructuring, the operational consequences are becoming increasingly visible.

At the FDA, there are growing signs that the workforce reduction is hampering drug review timelines. During any lapse in appropriations, the agency cannot accept new drug applications, generic drug applications, biological product applications, or medical device submissions that require user fee payments. Even outside of shutdown scenarios, the reduced staff is straining the agency's capacity to process the pipeline of treatments and devices awaiting approval, according to analysis by Holland and Knight.

At the CDC, the staffing crisis has collided with a public health emergency. The United States reported more than 1,100 measles cases in just the first two months of 2026, roughly six times higher than a typical full year, according to Healthline. By late March, cases had climbed to approximately 1,575 with three confirmed deaths. The CDC's response has been criticized as slow and under-resourced. The agency denied a request from Milwaukee for assistance with its lead crisis, reportedly citing staffing constraints. A review of the country's measles elimination status was postponed from April to November, and CDC leadership acknowledged widespread operational challenges during internal staff meetings.

At the NIH, important biomedical research programs and clinical trials have been disrupted. Longtime scientific experts have departed, and concerns have grown about political influence creeping into decision-making at agencies that have historically operated on scientific consensus.

Sources inside multiple HHS divisions described working conditions that felt like a skeleton crew, with unclear directives, restrictions on external communications, and new bureaucratic hurdles slowing down essential work.

How Are State and Local Health Jobs Affected?

The federal cuts triggered a cascading effect on state and local health departments. When HHS moved to claw back more than $11 billion in COVID-19-related funding, health departments across the country began identifying hundreds of positions that would need to be eliminated.

Lori Tremmel Freeman, chief executive of the National Association of County and City Health Officials, told reporters that some positions disappeared overnight. The Trust for America's Health (TFAH) documented serious impacts in its 2025 annual report, warning that the proposed FY 2026 budget would slash the CDC's budget by 53 percent if adopted.

For healthcare workers at every level, from epidemiologists and clinical researchers to public health nurses and administrative staff, the landscape has shifted dramatically. Federal health employment, once considered among the most stable career paths in the country, now carries significant uncertainty.

The American Federation of State, County and Municipal Employees (AFSCME) has warned that the combined effect of layoffs and grant cuts threatens community health infrastructure that took decades to build, including programs for disease surveillance, maternal health, substance abuse treatment, and emergency preparedness.

Where Are the Healthcare Job Opportunities Now?

Despite the disruption, the broader healthcare labor market remains one of the strongest sectors for job seekers. The restructuring has shifted where opportunities exist rather than eliminating demand for healthcare talent altogether.

Private-sector healthcare systems, hospitals, and health technology companies are absorbing some of the displaced federal workforce. Professionals with regulatory expertise, clinical research backgrounds, and public health credentials are finding demand in pharmaceutical companies, biotech firms, and healthcare consulting.

State governments that are building their own capacity to replace lost federal support are hiring epidemiologists, data analysts, and public health administrators. Telehealth and digital health companies continue to expand, creating roles for professionals comfortable working at the intersection of healthcare and technology.

The shift also presents opportunities in healthcare compliance and regulatory affairs. As pharmaceutical companies navigate a changed FDA landscape, demand for professionals who understand the regulatory approval process has increased. Similarly, organizations focused on healthcare quality improvement and patient safety are seeking talent to fill gaps left by the downsizing of agencies like AHRQ.

Metaintro tracks these shifts daily, helping healthcare professionals and job seekers navigate a rapidly changing employment landscape.

What Does This Mean for Your Career?

Whether you are a displaced federal worker, a healthcare professional considering your next move, or someone exploring a career in public health, the HHS restructuring has reshaped the calculus.

Federal health careers are no longer the guaranteed stable path they once were. Professionals in this space should diversify their options, building skills that translate across public and private sectors. Regulatory knowledge, data science, clinical research management, and public health informatics are all areas where demand is outpacing supply.

For those directly affected by the layoffs, networking within professional associations, updating credentials, and considering contract or consulting roles can bridge the gap while the federal employment picture stabilizes. Many displaced HHS workers have found positions in state agencies, academic research institutions, and private healthcare organizations.

The measles crisis, drug approval delays, and research disruptions also signal that the country will eventually need to rebuild its public health capacity. When that reinvestment happens, experienced professionals will be in high demand.

People Also Asked

Q: How many HHS employees have been laid off since 2025?

A: The Department of Health and Human Services has lost more than 17,000 employees since early 2025, shrinking from a workforce of 92,000 to approximately 75,000. This includes roughly 10,000 who accepted voluntary separation offers, 10,000 who received formal reduction-in-force notices, and an additional 3,000 who left through attrition between fall 2025 and January 2026.

Q: Which HHS agencies lost the most workers?

A: The FDA lost approximately 3,500 employees (20 percent of its workforce), the CDC lost about 2,473 workers, and the NIH lost 1,312 staff members. Smaller agencies like the Agency for Healthcare Research and Quality and the Administration for Community Living lost more than 50 percent of their staff, while NIOSH expected to cut roughly two-thirds of its workforce.

Q: Are there still healthcare jobs available after the HHS cuts?

A: Yes. While federal health employment has contracted significantly, private-sector healthcare, biotech, pharmaceutical, and state-level public health organizations are actively hiring. Roles in regulatory affairs, clinical research, health data analytics, telehealth, and healthcare compliance are in particularly high demand as the industry adjusts to the restructured federal landscape. Metaintro can help you find the right opportunities.

Looking for your next opportunity? The healthcare job market is changing fast, but demand for skilled professionals has not disappeared. Metaintro delivers daily job market insights, career resources, and personalized alerts to help you stay ahead. Sign up today and take the next step in your healthcare career.